SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 197 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $224 | -54.4% | 381 | 0.0% | 0.00% | – |
Q2 2023 | $491 | -26.3% | 381 | 0.0% | 0.00% | – |
Q1 2023 | $666 | -44.3% | 381 | 0.0% | 0.00% | – |
Q4 2022 | $1,196 | -40.2% | 381 | 0.0% | 0.00% | – |
Q3 2022 | $2,000 | -50.0% | 381 | -63.6% | 0.00% | – |
Q2 2022 | $4,000 | -33.3% | 1,048 | 0.0% | 0.00% | – |
Q1 2022 | $6,000 | -25.0% | 1,048 | 0.0% | 0.00% | – |
Q4 2021 | $8,000 | +166.7% | 1,048 | +175.1% | 0.00% | – |
Q3 2021 | $3,000 | -40.0% | 381 | 0.0% | 0.00% | – |
Q2 2021 | $5,000 | 0.0% | 381 | 0.0% | 0.00% | – |
Q1 2021 | $5,000 | -16.7% | 381 | 0.0% | 0.00% | – |
Q4 2020 | $6,000 | +50.0% | 381 | 0.0% | 0.00% | – |
Q3 2020 | $4,000 | +33.3% | 381 | 0.0% | 0.00% | – |
Q2 2020 | $3,000 | 0.0% | 381 | -11.6% | 0.00% | – |
Q1 2020 | $3,000 | -25.0% | 431 | 0.0% | 0.00% | – |
Q4 2019 | $4,000 | -63.6% | 431 | -63.5% | 0.00% | – |
Q3 2019 | $11,000 | +175.0% | 1,181 | +210.0% | 0.00% | – |
Q2 2019 | $4,000 | 0.0% | 381 | 0.0% | 0.00% | – |
Q1 2019 | $4,000 | 0.0% | 381 | 0.0% | 0.00% | – |
Q4 2018 | $4,000 | -33.3% | 381 | 0.0% | 0.00% | – |
Q3 2018 | $6,000 | +20.0% | 381 | 0.0% | 0.00% | – |
Q2 2018 | $5,000 | – | 381 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,400,000 | $12,320,000 | 4.56% |
EcoR1 Capital, LLC | 2,568,119 | $22,599,000 | 4.01% |
FIC CAPITAL INC | 960,338 | $8,451,000 | 3.48% |
Opaleye Management Inc. | 580,000 | $5,104,000 | 2.13% |
DAFNA Capital Management LLC | 225,000 | $1,980,000 | 1.41% |
RA Capital Management | 1,250,000 | $11,000,000 | 1.26% |
Iguana Healthcare Management, LLC | 215,000 | $1,892,000 | 1.07% |
Avoro Capital Advisors LLC | 800,000 | $7,040,000 | 0.89% |
WASATCH ADVISORS LP | 6,930,535 | $60,989,000 | 0.85% |
Cormorant Asset Management, LP | 400,000 | $3,520,000 | 0.58% |